s u m m a r y Population aging and osteoporosis are global public health challenges. Osteoporosis markedly increases the risk of fractures, and further morbidity and mortality. Calcium is a major constituent of the bone and vitamin D helps maintain calcium homeostasis. Calcium and vitamin D supplements have long been recognized as the cornerstones for prevention and management of osteoporosis and fractures. Although the associations between calcium and vitamin D supplementation and bone mineral density, fracture prevention, and potential adverse outcomes from available evidence are inconsistent, the Institute of Medicine Committee and the American Geriatrics Society support a key role of calcium and vitamin D in skeletal health. There is insufficient evidence to conclude that calcium with or without vitamin D supplementation increases the risk of cardiovascular events and cancer. Older adults should obtain at least 1000 IU/day of vitamin D with 1000e1200 mg/day of calcium to reduce the risk of fractures. The actual supplementation levels of calcium and vitamin D should be advised individually to specific patient or situation.
Introduction
Population aging is a phenomenon that occurs worldwide. With aging, a gradual loss of bone mass results in osteopenia and osteoporosis. Osteoporosis, falling, and related fragile fracture have been identified as being a serious public health issue. The cumulative lifetime fracture risk for a 50-year woman with osteoporosis is as high as 60% 1 . For elderly people in residential care facilities or nursing homes, the annual risk of fall is > 50% 2 . The most common sites of osteoporotic fracture are the hip, humerus, wrist, and spine 3 . Among these fractures, hip fracture is life-threatening 4 .
Approximately 5e20% of these patients die within 1 year, and 50% of survivors have difficulties performing daily activities and, thus, need extra care 5 . The direct medical expenditure for nonfatal fallrelated fractures is approximately $12 billion in 2013 6 . Many elders who fall have high incidence of recurrent falls 7 . They will develop a fear of fall and tend to limit their activities, resulting in reduced mobility and loss of physical fitness and bone mass.
Effective prevention of osteoporotic fracture needs comprehensive management, including healthy lifestyle, regular exercise, adequate nutrition, safe living environment, and reducing medication dosage. Calcium and vitamin D supplements have long been recognized as the cornerstones for prevention and management of osteoporosis and fractures. Calcium is a major constituent of bone. It would make sense that calcium supplementation or the consumption of calcium-rich foods was helpful in maximizing peak bone mass, retaining acquired bone mass, and thus reducing the risk of osteoporosis. A recent study has shown that women took calcium supplements for about half of their daily calcium requirement to meet the National Academy of Sciences guidelines, some even exceeding daily recommended intakes 8 .
Vitamin D, a group of hormones rather than vitamins, is majorly synthesized in the skin during exposure to UV B and less absorbed from the diet. 25 Because the primary goal of the calcium and vitamin D supplementation is the prevention of osteoporotic fracture, the effectiveness of interventions should best be measured using fracture outcomes. Although few review articles have reported that taking vitamin D alone is unlikely to prevent fracture and vitamin D plus calcium did appear to reduce risk of hip fractures among institutionalized adults 24, 25 , most trials and meta-analysis of vitamin D with or without calcium supplement showed statistically significant reduction in fractures. Vitamin D doses of 400 IU and lower did not show antifracture efficacy. There was a doseeresponse relationship between supplemental vitamin D and fracture reduction 26 . Oral vitamin D dose of 700e800 IU/day, alone or in combination with calcium supplementation, reduced the risk of hip fracture [n ¼ 5572; pooled relative risk (RR) 0.74; 95% confidence interval (CI) 0.61e0.88) and any nonvertebral fracture (n ¼ 6098; pooled RR 0.77; 95% CI 0.68e0.87) in ambulatory or institutionalized elderly persons (age 60 years) 27 . For higher doses of vitamin D (median, 800 IU daily; range, 792e2000; n ¼ 3966 individuals), the reduction rate was 30% [hazard ratio (HR) 0.70; 95% CI 0.58e0.86; p < 0.001) for hip fractures and 14% (HR 0.86; 95% CI 0.76e0.96; p ¼ 0.007) for nonvertebral fractures. The effect was independent of age, sex, additional calcium intake, and type of dwelling 28 . However, extremely high doses of vitamin D were not consistently associated with greater benefits and might led to potential adverse effects. An annual intramuscular injection of 300,000 IU vitamin D 2 was ineffective in reducing nonvertebral fractures 29 . Furthermore, an annual oral administration of 500,000 IU D 3 resulted in an increased risk of falls (RR 1.15; 95% CI 1.02e1.30; p ¼ 0.03) and fractures (RR 1.26; 95% CI 1.00e1.59; p ¼ 0.047) 30 . Data on the effects of calcium supplementation on bone mineral density and fracture rates in the general population are conflicting. Calcium and calcium plus vitamin D (CaD) were associated with a reduction in bone loss 17, 31, 32 and fracture risk 31, 33 . On the contrary, Grant et al 34 reported that the incidence of new, low-trauma fractures did not differ significantly: between with the use of oral calcium (1000 mg) and placebo; between oral vitamin D3 (800 IU) and placebo; or between combined Vitamin D (800 IU) and calcium (1000 mg) supplements and placebo. Another two meta-analyses 17, 35 and the US Preventive Services Task Force's recommendations 24 confirmed these findings. However, some researchers performed several meta-analyses with subgroup stratification and found that the fracture risk reduction was significantly greater in trial with a high adherence rate of calcium and vitamin D supplementation 17, 31, 36 . The fracture risk reductions were significantly greater among women who took at least 80% of their study supplements (HR 0.71; 95% CI 0.52e0.97) 17 or followed 5 years of treatment (HR 0.65; 95% CI 0.44e0.98) 36 , and among participants with compliance rate of 80% (RR 0.76; 95% CI 0.67e0.86; p ¼ 0.002) 31 . The antifracture efficacy was better in individuals who were older than 70 years, lived in institutions 18, 25, 31, 37 , and had low bodyweight 31 . In summary, calcium and CaD were associated with a reduction in bone loss. Vitamin D doses of 400 IU and lower did not show antifracture efficacy. A daily oral administration of 800e2000 IU vitamin D, with or without calcium supplementation, may reduce the risk of hip fracture. The fracture risk reductions were significantly greater among participants with high compliance rate and longer administration. 19, 51 , colorectal cancer 51, 52 , breast cancer 51e54 , and cancer-related mortality 19, 51 . Significant treatment interactions on incident cancer were found for a family history of cancer 20 , highest dose of vitamin D 20, 52, 55 , and smoking 20 .
Potential adverse outcomes of calcium and vitamin D
Calcium is the major component of 85% of kidney stones. Urinary tract stone occurrence was more common in women who took supplemental CaD than placebo (HR 1.17; 95% CI 1.02e1.34) in the WHI trial 17, 56 , consistent with previous research 16 . In contrast with adverse effects of calcium supplements on renal calculi, dietary calcium may lower new kidney stone formation 16 through binding of dietary oxalate and calcium in the intestinal lumen that decreases urine calcium oxalate supersaturation. In summary, consumption of calcium from supplements might increase the risk of adverse cardiovascular events and urinary tract stones, but not from diet. No statistically significant associations between vitamin D and cardiovascular events, stroke, and death were reported. The available evidence is still insufficiently robust to draw conclusions the influence of calcium/vitamin D intake on cancer risk.
Current recommendations and daily intakes of calcium and vitamin D
After reviewing > 1000 higher-quality studies, the Institute of Medicine updated the estimated average requirement (intake that meets the needs of 50% of the population) and recommended dietary allowance (RDA; intake that covers needs of 97.5% of the population) intakes for calcium and vitamin D of North American population on November 30, 2010 9,48 ( Table 1 ). The Committee concluded that available scientific evidence supports a key role of calcium and vitamin D in skeletal health, consistent with a causeand-effect relationship. However, for their roles in cancer, including cardiovascular disease, diabetes, and autoimmune disorders, the evidence was inconsistent. The RDA for calcium is 1000 mg/day for men aged 51e70 years, and 1200 mg/day for women aged 51e70 years and for women and men aged 71 years. The RDA for vitamin D was 600 IU/day for adults aged 51e70 years, and 800 IU/day for adults aged 71 years and over to maintain serum 25(OH)D at or above 20 ng/mL. On the promise that vitamin D deficiencies are common among all age groups and that few foods contain vitamin D, the Endocrine Society prefers 30 ng/mL (75mM) of 25(OH)D as the target level for maximal benefits and recommends daily supplements of 1500e2000 IU are required for US, Canadian, and European adults 57 (Table 1) , although the Institute of Medicine committee disagree with these viewpoints 58 .
In 2014, the American Geriatrics Society stated that clinicians are strongly advised to recommend vitamin D supplementation of at least 1000 IU/day with calcium to older adults (age > 65 years) residing in the community or institutional settings to reduce the risk of fractures and falls. A serum 25(OH)D concentration of 30 ng/ mL (75mM) should be a minimal goal for older adults, particularly for frail adults, who are at higher risk of falls, injuries, and fractures. An average daily vitamin D input of 4000 IU from all sources is required to result in 92% of older adults in the United States achieving target 25(OH)D levels. Routine laboratory testing for 25(OH)D serum concentrations before supplementation begins or for safety or efficacy when supplementation is within the recommended limits are not necessary. Clinicians may monitor 25(OH)D after 4 months of vitamin D 3 supplementation to confirm that appropriate levels have been achieved 46 .
Increasing dietary calcium should be considered first. When adequate dietary calcium intake cannot be achieved or patients are unwilling to do so, calcium supplement tablets could be used. Calcium carbonate is bioavailable when taken with a meal. Calcium citrate is recommended for individuals with a history of renal stones 59 . Very few foods are naturally rich in vitamin D. Additional vitamin D supplements are usually needed to meet the recommendations for daily intake. Natural sources of vitamin D and calcium are listed in Table 2 . 
Summary
Calcium and vitamin D play a key role in skeletal health. However, the evidence of potential adverse outcomes of calcium and vitamin D supplementation is inconsistent. Although emerging evidence suggests that calcium with or without vitamin D supplementation might increase the risk of myocardial infarction, most experts conclude that individuals who do not obtain sufficient intake of calcium and vitamin D from their diet should not be advised to avoid using calcium and vitamin D supplementation 60 .
While the primary purpose of supplementation is to reduce the risk of fractures, vitamin D supplementation of at least 1000 IU/day with calcium of 1000e1200 mg/day to older adults is recommended, particularly to frail adults 46, 48 . It seems that vitamin D has a biphasic effect for bone mass and U-shaped associations of some outcomes 23,47e49 . The supplementation levels of vitamin D need adjustments for sun exposure, skin pigmentation, and high body mass. Clinicians should review patient's calcium and vitamin D intake from all sources and individualize decision making to the specific patient or situation.
